To investigate the clinical impact of CD301 positivity on osteosarcoma patient survival, we stained a second TMA with 50 osteosarcoma tumors with known corresponding survival data of the patients (Figure 1K, Supplementary Figure S4. Here, CLEC10A is linked to osteosarcoma.